Laguna Bio
Berkeley, United States · Founded 2022
- Headquarters
- Berkeley, California
- Employees
- 1–10
- Founded
- 2022
- Business Model
- B2B
- Website
- lagunabio.com
- Last Round
- SeedDec 2022
- Rounds
- 1
About
Laguna Bio is developing next-generation cancer immunotherapy using its QUAIL platform, which is based on food-borne microbes modified to be harmless while retaining the ability to provoke a large and durable immune response. The activated immune cells generated by QUAIL can be directed to attack tumors alone or in combination with other immunotherapies that provide tumor-specific targeting, including bispecific antibodies.
Summary
Laguna Bio is a Biotech company based in Berkeley, United States, founded in 2022. Its most recent funding was a Seed round in Dec 2022. Investors include IndieBio and SOSV.
Tech & App Stack
3 technologies & apps tracked
Create a free account — 25 credits a month to unlock the full tech & app stack, funding history, and valuations.
Sign up to view the funding chart
Create a free account — 25 credits a month to unlock funding history, valuations, and tech stacks.
Funding History
Dec 2022
Investors
Similar Companies
China's leading blood products manufacturer
Global contract research organization providing comprehensive drug development and laboratory ser...
Global fertility clinics platform
Specialty pharmaceutical company
Biopharmaceutical services company
Biotech advancing cellular rejuvenation programming to restore cell health and reverse disease.